New approach for cancer prevention in BRCA1 mutation-positive women from Josef Penninger

(US Department of Defense Congressionally Directed Medical Research Programs) With his DoD BCRP Innovator Award, Dr. Penninger investigated whether RANKL inhibition could be used to prevent breast cancer in mouse models.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2hB0YRf